- Home
- GLOBAL THREATS
- Future of Business
- Sections
- Topics
- Editions
As the Brexit deadline nears, uncertainty prevails after British MPs rejected the prime minister’s deal – twice. StrategicRISK gathers the reaction of European risk managers, including the chief risk officer of French pharmaceutical company, Ipsen, who has prepared the business for a ‘hard Brexit’. Sara Benwell reports
We’re glad you’re finding our content useful. For continued access to free content on the site please take a few moments to register, or sign in if you have already registered.